share_log

Day One Biopharmaceuticals | 8-K: Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress

SEC announcement ·  Feb 26 22:24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more